Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

FDA Speeds Up Generic Approval Process

Posted on August 30th, 2017 by in Pharmacovigilance

Healthcare has been in the spotlight for much of the year so far, as Congress has wrestled with the difficult question of how to make it both better and more affordable.

Continue reading “FDA Speeds Up Generic Approval Process” »

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 by in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades Continue reading “Selecting Anti-Melanoma Drug Targets” »

Cancer Immunotherapy Webinar on September 12: Register Now

Posted on August 25th, 2017 by in Pharma R&D

After decades of being treated with a fairly typical combination of surgery and therapies, cancer is now being met with exciting new treatments that are more targeted and often less hard on the patient. Continue reading “Cancer Immunotherapy Webinar on September 12: Register Now” »

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 by in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »

  1. 1
  2. 2
  3. 3
  4. 4